Lappaconitine, extracted form the roots of Aconitum carmichaeli Debx, has neurotoxic, cardiotoxic and strong analgesic activities that does not involve the opioid receptor, and further suggest that the central nervous system may be involved in the action

Lappaconitine, extracted form the roots of Aconitum carmichaeli Debx, has neurotoxic, cardiotoxic and strong analgesic activities that does not involve the opioid receptor, and further suggest that the central nervous system may be involved in the action

129 articles related to:  Identification in the μ-opioid receptor of cysteine residues responsible for inactivation of ligand binding by thiol alkylating and reducing agents

129 articles related to: Identification in the μ-opioid receptor of cysteine residues responsible for inactivation of ligand binding by thiol alkylating and reducing agents

Genome-wide transcriptome analysis of hippocampus in rats indicated that TLR/NLR signaling pathway was involved in the pathogenisis of depressive disorder induced by chronic restraint stress

Genome-wide transcriptome analysis of hippocampus in rats indicated that TLR/NLR signaling pathway was involved in the pathogenisis of depressive disorder induced by chronic restraint stress

New research shows that it’s possible to activate opioid receptors with light instead of pain-killing drugs.

Light – not pain-killing drugs – used to activate brain’s opioid receptors

New research shows that it’s possible to activate opioid receptors with light instead of pain-killing drugs.

A cellular mechanism has been discovered by which kappa opioid receptors (KORs) drive anxiety. These proteins inhibit the release of the neurotransmitter glutamate in a part of the brain that regulates emotion. KORs are targets for the treatment of addiction and anxiety disorders.

How kappa opioid receptors drive anxiety

A cellular mechanism has been discovered by which kappa opioid receptors (KORs) drive anxiety. These proteins inhibit the release of the neurotransmitter glutamate in a part of the brain that regulates emotion. KORs are targets for the treatment of addiction and anxiety disorders.

Light -- not pain-killing drugs -- used to activate brain's opioid receptors

Light -- not pain-killing drugs -- used to activate brain's opioid receptors

Medical Science,Science News,Opioid Receptor,Neuroscience,The Brain,Science Nature,Neurology,Spinal Cord,St Louis

Light -- not pain-killing drugs -- used to activate brain's opioid receptors

Light -- not pain-killing drugs -- used to activate brain's opioid receptors

Kinetic Machine Learning Unravels Ligand-Directed Conformational Change of μ Opioid Receptor | bioRxiv

Kinetic Machine Learning Unravels Ligand-Directed Conformational Change of μ Opioid Receptor | bioRxiv

Pain patients who do not respond to the analgesic properties of opioids have a chance of being genetically incapable of generating the clinically active metabolite of these medications. Get tips on when to suspect a patient has CYP-2D6 deficiency.

Pain patients who do not respond to the analgesic properties of opioids have a chance of being genetically incapable of generating the clinically active metabolite of these medications. Get tips on when to suspect a patient has CYP-2D6 deficiency.

Can Blocking Opioid Receptors Yield New Alcoholism Treatment?

Can Blocking Opioid Receptors Yield New Alcoholism Treatment?

Pinterest
Search